title: Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health.
abstract: BACKGROUND
  The prevalence, severity, and functional implications of adverse oral health outcomes attributed to head and neck cancer therapy are largely undefined. We report development of an oral health outcome subscale for the Vanderbilt Head and Neck Symptom Survey (VHNSS).
  
  
  METHODS
  Oral health outcome questions were formulated through literature review and consultation with an expert panel. Questions were incorporated into the VHNSS resulting in a 50-item survey, scored 0 (none) to 10 (severe). The tool was administered to 70 subjects who completed radiation to assess for feasibility.
  
  
  RESULTS
  Patient acceptance was high with a completion time <10 minutes. A full range of scores was noted for 46 of 50 questions. Oral health symptom burden was high early and late posttreatment.
  
  
  CONCLUSIONS
  The VHNSS version 2.0 was feasible and could be completed in a timely manner. Validation studies are ongoing. The high prevalence of adverse oral health outcomes warrants further study.
authors: Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
authors: Emily
authors: E
authors: Cooperstein
authors: Jill
authors: J
authors: Gilbert
authors: Joel B
authors: JB
authors: Epstein
authors: Mary S
authors: MS
authors: Dietrich
authors: Stewart M
authors: SM
authors: Bond
authors: Sheila H
authors: SH
authors: Ridner
authors: Nancy
authors: N
authors: Wells
authors: Anthony
authors: A
authors: Cmelak
authors: Barbara A
authors: BA
authors: Murphy
mesh_terms: D001066:Appetite; D059248:Chemoradiotherapy / Q000009:adverse effects*; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D003680:Deglutition Disorders / Q000209:etiology; D003807:Dentin Sensitivity / Q000209:etiology; D003778:Dentures; D005260:Female; D006258:Head and Neck Neoplasms / Q000150:complications / Q000628:therapy*; D006311:Hearing Disorders / Q000209:etiology; D006801:Humans; D007568:Jaw / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009068:Movement / Q000502:physiology; D052016:Mucositis / Q000209:etiology; D009093:Mucus; D009333:Neck / Q000503:physiopathology; D000857:Olfaction Disorders / Q000209:etiology; D009909:Oral Health; D010146:Pain / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects*; D016059:Range of Motion, Articular / Q000502:physiology; D012720:Severity of Illness Index; D012785:Shoulder Joint / Q000503:physiopathology; D013064:Speech Disorders / Q000209:etiology; D011795:Surveys and Questionnaires; D018677:Tooth Injuries / Q000209:etiology; D014832:Voice Disorders / Q000209:etiology; D015431:Weight Loss; D014987:Xerostomia / Q000209:etiology